| Drug Name |
Olsalazine |
| Drug ID |
BADD_D01607 |
| Description |
Olsalazine is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease and Ulcerative Colitis. Olsalazine is a derivative of salicylic acid. Inactive by itself (it is a prodrug), it is converted by the bacteria in the colon to mesalamine. Mesalamine works as an anti-inflammatory agent in treating inflammatory diseases of the intestines. |
| Indications and Usage |
For the treatment of Inflammatory Bowel Disease and Ulcerative Colitis. |
| Marketing Status |
approved |
| ATC Code |
A07EC03 |
| DrugBank ID |
DB01250
|
| KEGG ID |
D08295
|
| MeSH ID |
C032587
|
| PubChem ID |
22419
|
| TTD Drug ID |
D00KRE
|
| NDC Product Code |
Not Available |
| UNII |
ULS5I8J03O
|
| Synonyms |
olsalazine | azodisalicylate | Dipentum | Rasal | olsalazine sodium | disodium 5,5'-azodisalicylate | sodium diazosalicylate | olsalazine, disodium salt | azodisal sodium | disodium azodisalicylate | CJ-91B |
